A novel oral delivery system consisting in 鈥渄rug-in cyclodextrin-in nanostructured lipid carriers鈥?for poorly water-soluble drug: Vinpocetine

详细信息    查看全文

• 作者：Congcong Lin^a ; Fen Chen^a ; Tiantian Ye^a ; Lina Zhang^a ; Wenji Zhang^a ; Dandan Liu^b ; Wei Xiong^a ; Xinggang Yang^a ; Weisan Pan^a ; ^{pwslsm@163.com" class="auth_mail}
• 关键词：Nanostructured lipid carriers (NLC) ; Cyclodextrins ; Vinpocetine ; Oral bioavailability ; Poorly water-soluble drugs
• 刊名：International Journal of Pharmaceutics
• 出版年：25 April, 2014
• 年：2014
• 卷：465
• 期：1-2
• 页码：90-96
• 全文大小：1489 K

文摘

The purpose of this study was to develop a new delivery system based on drug cyclodextrin (CD) complexation and loading into nanostructured lipid carriers (NLC) to improve the oral bioavailability of vinpocetine (VP). Three different CDs and three different methods to obtain solid vinpocetine-cyclodextrin-tartaric acid complexes (VP-CD-TA) were contrasted. The co-evaporation vinpocetine-尾-cyclodextrin-tartaric acid loaded NLC (VP-尾-CD-TA COE-loaded NLC) was obtained by emulsification ultrasonic dispersion method. VP-尾-CD-TA COE-loaded NLC was suitably characterized for particle size, polydispersity index, zeta potential, entrapment efficiency and the morphology. The crystallization of drug in VP-CD-TA and NLC was investigated by differential scanning calorimetry (DSC). The in vitro release study was carried out at pH 1.2, pH 6.8 and pH 7.4 medium. New Zealand rabbits were applied to investigate the pharmacokinetic behavior in vivo. The VP-尾-CD-TA COE-loaded NLC presented a superior physicochemical property and selected to further study. In the in vitro release study, VP-尾-CD-TA COE-loaded NLC exhibited a higher dissolution rate in the pH 6.8 and pH 7.4 medium than VP suspension and VP-NLC. The relative bioavailability of VP-尾-CD-TA COE-loaded NLC was 592% compared with VP suspension and 92% higher than VP-NLC. In conclusion, the new formulation significantly improved bioavailability of VP for oral delivery, demonstrated a perspective way for oral delivery of poorly water-soluble drugs.